ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
Risks of an adverse event following influenza vaccination are far less common than complications related to influenza itself, and the adverse events are generally localised and mild.
Overview of all the data available on the COVID-19 pandemic, including the The European Respiratory Virus Surveillance Summary (ERVISS) and variants of concern.
The Global Influenza Surveillance and Response System (GISRS), led by WHO, is used for the international virological and epidemiological surveillance of human influenza.
Seasonal influenza is a vaccine-preventable disease and annual influenza vaccination is the most effective way to prevent influenza. ECDC continues to emphasise that all Europeans who are recommended to have the influenza vaccine should get vaccinated.